DeepNoid Inc
KOSDAQ:315640
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DeepNoid Inc
Cash & Cash Equivalents
DeepNoid Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DeepNoid Inc
KOSDAQ:315640
|
Cash & Cash Equivalents
₩4B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Cash & Cash Equivalents
₩14.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Cash & Cash Equivalents
₩10.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
1%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Cash & Cash Equivalents
₩19.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Cash & Cash Equivalents
₩1B
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
J
|
JLK Inc
KOSDAQ:322510
|
Cash & Cash Equivalents
₩9.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
DeepNoid Inc
Glance View
Deepnoid, Inc. operates artificial intelligence medical imaging analytics platform. The company is headquartered in Seoul, Seoul and currently employs 115 full-time employees. The company went IPO on 2021-08-17. The firm a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The firm's main products include DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS.
See Also
What is DeepNoid Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
4B
KRW
Based on the financial report for Dec 31, 2024, DeepNoid Inc's Cash & Cash Equivalents amounts to 4B KRW.
What is DeepNoid Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
41%
Over the last year, the Cash & Cash Equivalents growth was -81%. The average annual Cash & Cash Equivalents growth rates for DeepNoid Inc have been -37% over the past three years , 41% over the past five years .
